Clinical trials
Phase 1/2 Liver Cirrhosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corewell Health East | 1 |
| M.D. Anderson Cancer Center | 1 |
| Massachusetts General Hospital | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 5 |
| Fatty Liver | 3 |
| Anemia, Aplastic | 1 |
| Colorectal Neoplasms | 1 |
| Constriction, Pathologic | 1 |
| Fibrosis | 1 |
| Hepatic Encephalopathy | 1 |
| Liver Diseases | 1 |
| Liver Neoplasms | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.